(Q42705157)

5 November 2017

title

Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis (English)

1 reference

5 November 2017

1 reference

1 reference

Brittany G Craiglow

1

1 reference

5 November 2017

Brett A King

series ordinal

2

1 reference

5 November 2017

language of work or name

English

0 references

publication date

18 June 2014

1 reference

Journal of Investigative Dermatology

5 November 2017

published in

1 reference

5 November 2017

volume

134

1 reference

5 November 2017

issue

12

1 reference

5 November 2017

page(s)

2988-2990

1 reference

Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis

5 November 2017

cites work

1 reference

12 December 2020

Treatment of Alopecia Areata by Anthralin-Induced Dermatitis

1 reference

12 December 2020

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.

1 reference

12 December 2020

Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15

1 reference

12 December 2020

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

1 reference

12 December 2020

Tofacitinib (CP-690,550), an oral Janus kinase inhibitor, improves patient-reported outcomes in a phase 2b, randomized, double-blind, placebo-controlled study in patients with moderate-to-severe psoriasis

1 reference

12 December 2020

Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.

1 reference

12 December 2020

Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550).

1 reference

12 December 2020

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study.

1 reference

12 December 2020

Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?

1 reference

12 December 2020

Identifiers

DOI

10.1038/JID.2014.260

1 reference

Dimensions Publication ID

5 November 2017

1041994162

0 references

1 reference